www.nature.com/aps
npg
Al-Aboudi A et al
8
formed the synthesis; Uzma MAHMOOD has performed
docking studies; Asaad KHALID has supervised the in vitro
enzyme inhibition studies, and analyzed the results; Zaheer
UL-HAQ has supervised the in sillico studies and analyzed the
results.
2006; 41: 1253–61.
1
5 Rasras AJ, Al-Tel TH, Al-Aboudi A, Al-Qawasmeh RA. Synthesis and
antimicrobial activity of cholic acid hydrazone analogues. Eur J Med
Chem 2010; 45: 2307–13.
6 Al-Aboudi A, Odeh H, Khalid A, Naz Q, Choudhary MI. Butyrylcholine-
sterase inhibitory activity of testosterone and some of its metabolites.
1
J Enzyme Inhib Med Chem 2009; 24: 553–8.
7 Huang N, Shoichet BK, Irwin JJ. Benchmarking sets for molecular
References
1
1
Majnaric-Trtica L. Update on biological, social and economical aspect
docking. J Med chem 2006; 49: 6789–801.
of Alzheimer’s disease and other dementia. Period Biol 2009; 111:
1
8 Erickson J A, Jalaie M, Robertson DH, Lewis RA, Vieth M. Lessons in
molecular recognition: the effects of ligand and protein flexibility on
molecular docking accuracy. J Med Chem 2004; 47: 45–55.
9 Clark M, Meshkat S, Talbot GT, Carnevali P, Wiseman JS. Fragment-
based computation of binding free energies by systematic sampling.
J Chem Inf Model 2009; 49: 1901–13.
381–8.
2
Laursen B, Mork A, Plath N, Kristiansen U, Bastlund JF. Impaired
hippocampal acetylcholine release parallels spatial memory deficits
in Tg2576 mice subjected to basal forebrain cholinergic degeneration.
Brain Res 2014; 1543: 253–62.
1
3
4
Greig NH, Utsuki T, Yu Q, Zhu X, Holloway HW, Perry T, et al. A new
therapeutic target in Alzheimer’s disease treatment: attention to
butyrylcholinesterase. Curr Med Res Opin 2001; 17: 159–65.
Loizzo MR, Tundis R, Menichini F, Menichini F. Natural products
and their derivatives as cholinesterase inhibitors in the treatment of
neurodegenerative disorders: an update. Curr Med Chem 2008; 15:
2
0 Jain AN. Bias, reporting, and sharing: computational evaluations of
docking methods. J Comput Aided Mol Des 2008; 22: 201–12.
21 Kellenberger E, Rodrigo J, Muller P, Rognan D. Comparative evalua-
tion of eight docking tools for docking and virtual screening accuracy.
Proteins 2004; 57: 225–42.
22 Chiou SY, Huang CF, Hwang MT, Lin G. Comparison of active sites of
butyrylcholinesterase and acetylcholinesterase based on inhibition
1209–28.
5
Sener B, Orhan I. Exploring Turkish biodiversity: A rich source of
chemical diversity for drug leads discovery. Pure Appl Chem 2011;
by geometric isomers of benzene-di-N-substituted carbamates.
J
Biochem Mol Toxicol 2009; 23: 303–8.
83: 1699–707.
2
3 Sekutor M, Mlinaric-Majerski K, Hrenar T, Tomic S, Primozic I.
Adamantane-substituted guanylhydrazones: novel inhibitors of butyryl-
cholinesterase. Bioorg Chem 2012; 41–42: 28–34.
6
Lekishvili N, Lekashvili O, Zurabishvili D, Fachulia Z, Giorgadze
K. Synthesis and study of new adamantane-containing hydrazide-
hydrazone ligands and coordination compounds based on them. Oxid
Commun 2012; 35: 457–75.
El-Emam AA, Alrashood KA, Al-Omar MA, Al-Tamimi AS. Synthesis
and antimicrobial activity of N′-heteroarylidene-1-adamantyl-
carbohydrazides and (±)-2-(1-adamantyl)-4-acetyl-5-5-(4-substituted
phenyl-3-isoxazolyl)-1,3,4-oxadiazolines. Molecules 2012; 17: 3475–
24 Ellman GL, Courtney KD, Featherstone RM. A new and rapid
colorimetric determination of acetylcholinesterase activity. Biochem
Pharmacol 1961; 7: 88–95.
7
2
5 Spitzer R, Jain AN. Surflex-Dock: Docking benchmarks and real-world
application J Comput Aided Mol Des 2012; 26: 687–99.
6 Jain AN. Surflex-Dock 2.1: robust performance from ligand energetic
modeling, ring flexibility, and knowledge-based search. J Comput
Aided Mol Des 2007; 21: 281–306.
2
83.
8
Hassan GS, El-Emam AA, Gad LM, Barghash AM. Synthesis, antimi-
crobial and antiviral testing of some new 1-adamantyl analogues.
Saudi Pharm J 2010; 18: 123–8.
Kadi AA, El-Brollosy NR, Al-Deeb OA, Habib EE, Ibrahim TM, El-Emam
AA. Synthesis, antimicrobial, and anti-inflammatory activities of novel
27 Miteva MA, Lee WH, Montes MO, Villoutreix BO. Fast structure-based
virtual ligand screening combining FRED, DOCK, and Surflex. J Med
Chem 2005; 48: 6012–22.
8 Jain AN. Surflex: fully automatic flexible molecular docking using a
molecular similarity-based search engine. J Med Chem 2003; 46:
9
2
2
3
2
-(1-adamantyl)-5-substituted-1,3,4-oxadiazoles and 2-(1-adamantyl-
amino)-5-substituted-1,3,4-thiadiazoles. Eur J Med Chem 2007; 42:
35–42.
0 Makovec F, Artusi R, Zanzola S, Rovati LC. Adamantane derivatives
4
99–511.
9 Pacchioni G, Clotet A, Marchand AP, Dongxia X, Bott SG. Synthesis of
Z)- and (E)-1,2-di(1-adamantyl)ethene and their respective reactions
with dichlorocarbene. Tetrahedron 1996: 52: 825–32.
0 Bormasheva KM, Nechaeva ON, Moiseev IK. Reactions of adamantyl-
substituted keto esters with hydrazine and phenylhydrazine. Russ J
Org Chem 2008; 44: 1760–4.
2
1
(
with neuroprotective, antidepressant and anti-ischaemic activities.
U S Pat 2006; 7145037 B2.
1
1 Yeh VSC, Patel JR, Yong H, Kurukulasuriya R, Fung S, Monzon K, et
al. Synthesis and biological evaluation of heterocycle containing
adamantane 11β-HSD1 inhibitors. Bioorg Med Chem Lett 2006; 16:
31 Al-Omar MA, Al-Abdullah ES, Shehata IA, Habib EE, Ibrahim TM, El-
5414–19.
Emam AA. Synthesis, antimicrobial, and anti-inflammatory activities
of novel 5-(1-adamantyl)-4-arylideneamino-3-mercapto-1,2,4-triazoles
and related derivatives. Molecules 2010; 15: 2526–50.
2 Nicolet Y, Lockridge O, Masson P, Fontecilla-Camps JC, Nachon F.
Crystal structure of human butyrylcholinesterase and of its complexes
with substrate and products. J Biol Chem 2003; 278: 41141–7.
3 Arendt T, Brückner MK, Lange M, Bigl V. Changes in acetylcholine-
sterase and butyrylcholinesterase in Alzheimer's disease resemble
embryonic development — a study of molecular forms. Neurochem Int
1
2 Chohan ZH, Pervez H, Khan KM, Supuran CT. Organometallic-based
antibacterial and antifungal compounds: transition metal complexes
of 1,1′-diacetylferrocene-derived thiocarbohydrazone, carbohydrazone,
thiosemicarbazone and semicarbazone. J Enzyme Inhib Med Chem
3
3
2005; 20: 81–9.
13 Rollas S, Gulerman N, Erdeniz H. Synthesis and antimicrobial activity
of some new hydrazones of 4-fluorobenzoic acid hydrazide and
3
1
-acetyl-2,5-disubstituted-1,3,4-oxadiazolines. Farmaco 2002; 57:
71–4.
4 Bedia KK, Elcin O, Seda U, Fatma K, Nathaly S, Sevim R, et al.
1992; 21: 381–96.
1
3
4 Kamal MA, Qu X, Yu QS, Tweedie D, Holloway HW, Li Y, et al. Tetra-
hydrofurobenzofuran cymserine, a potent butyrylcholinesterase
inhibitor and experimental Alzheimer drug candidate, enzyme kinetic
analysis. J Neural Transm 2008; 115: 889–98.
Synthesis and characterization of novel hydrazide-hydrazones and
the study of their structure-antituberculosis activity. Eur J Med Chem
Acta Pharmacologica Sinica